FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 03:47:00 2024-07-17 pm EDT | ||
| 2.97 EUR | -3.26% |
|
| Current month | -26.67% | ||
| 1 month | -35.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 2.97 | -3.26% |
| 24-07-16 | 3.07 | -3.46% |
| 24-07-15 | 3.18 | +3.25% |
| 24-07-12 | 3.08 | -9.14% |
| 24-07-11 | 3.39 | -5.57% |
Real-time BOERSE MUENCHEN
Last update July 17, 2024 at 03:47 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD2VEG |
| ISIN | DE000HD2VEG8 |
| Date issued | 2024-02-21 |
| Strike | 416.4 $ |
| Maturity | Unlimited |
| Parity | 26.24 : 1 |
| Emission price | 10.32 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.73 € |
|---|---|
| Lowest since issue | 2.96 € |
| Spread | 0.01 € |
| Spread % | 0.34% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
335.7
USD
Average target price
317.4
USD
Spread / Average Target
-5.44%
- Stock Market
- Certificates
- Certificat
